Correlation Between Neurocrine Biosciences and Artelo Biosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Neurocrine Biosciences and Artelo Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neurocrine Biosciences and Artelo Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neurocrine Biosciences and Artelo Biosciences, you can compare the effects of market volatilities on Neurocrine Biosciences and Artelo Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neurocrine Biosciences with a short position of Artelo Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neurocrine Biosciences and Artelo Biosciences.

Diversification Opportunities for Neurocrine Biosciences and Artelo Biosciences

-0.19
  Correlation Coefficient

Good diversification

The 3 months correlation between Neurocrine and Artelo is -0.19. Overlapping area represents the amount of risk that can be diversified away by holding Neurocrine Biosciences and Artelo Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Artelo Biosciences and Neurocrine Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neurocrine Biosciences are associated (or correlated) with Artelo Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Artelo Biosciences has no effect on the direction of Neurocrine Biosciences i.e., Neurocrine Biosciences and Artelo Biosciences go up and down completely randomly.

Pair Corralation between Neurocrine Biosciences and Artelo Biosciences

Given the investment horizon of 90 days Neurocrine Biosciences is expected to generate 0.45 times more return on investment than Artelo Biosciences. However, Neurocrine Biosciences is 2.21 times less risky than Artelo Biosciences. It trades about 0.39 of its potential returns per unit of risk. Artelo Biosciences is currently generating about -0.18 per unit of risk. If you would invest  11,913  in Neurocrine Biosciences on September 20, 2024 and sell it today you would earn a total of  1,632  from holding Neurocrine Biosciences or generate 13.7% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Neurocrine Biosciences  vs.  Artelo Biosciences

 Performance 
       Timeline  
Neurocrine Biosciences 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Neurocrine Biosciences are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent forward indicators, Neurocrine Biosciences showed solid returns over the last few months and may actually be approaching a breakup point.
Artelo Biosciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Artelo Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent basic indicators, Artelo Biosciences is not utilizing all of its potentials. The newest stock price mess, may contribute to short-term losses for the institutional investors.

Neurocrine Biosciences and Artelo Biosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Neurocrine Biosciences and Artelo Biosciences

The main advantage of trading using opposite Neurocrine Biosciences and Artelo Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neurocrine Biosciences position performs unexpectedly, Artelo Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Artelo Biosciences will offset losses from the drop in Artelo Biosciences' long position.
The idea behind Neurocrine Biosciences and Artelo Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Other Complementary Tools

Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years